Bilateral acute macular neuroretinopathy in a young woman after the first dose of Oxford–AstraZeneca COVID-19 vaccine

PURPOSE: To report a case of bilateral acute macular neuroretinopathy following the first dose of Oxford-AstraZeneca COVID-19 (coronavirus disease 2019) vaccine in a young, Caucasian, and healthy woman. OBSERVATIONS: A 25-year-old Caucasian female patient presented to the ophthalmology department of...

Descripción completa

Detalles Bibliográficos
Autores principales: Gabrielle, Pierre-Henry, Baudin, Florian, Ben Ghezala, Ines, Meillon, Cyril, Bron, Alain Marie, Arnould, Louis, Creuzot-Garcher, Catherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769920/
https://www.ncbi.nlm.nih.gov/pubmed/35075438
http://dx.doi.org/10.1016/j.ajoc.2022.101281

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769920/
https://www.ncbi.nlm.nih.gov/pubmed/35075438
http://dx.doi.org/10.1016/j.ajoc.2022.101281

Ejemplares similares